Achievement of long duration methotrexate exposure with concurrent low dose thymidine protection: Influence on methotrexate pharmacokinetics
- 1 November 1980
- journal article
- research article
- Published by Elsevier
- Vol. 16 (11) , 1427-1432
- https://doi.org/10.1016/0014-2964(80)90051-1
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- The clinical pharmacology of methotrexate.new applications of an old drugCancer, 1978
- Analysis of the cycling and noncycling cell population of human solid tumorsCancer, 1977
- Cell cycle parameters in human solid tumorsCancer, 1977
- PREVENTION OF METHOTREXATE TOXICITY BY THYMIDINE INFUSIONS IN HUMANS1977
- The reversal of methotrexate toxicity by thymidine with maintenance of antitumour effectsNature, 1975
- Studies of folate compounds in natureArchives of Biochemistry and Biophysics, 1974
- Polygammaglutamyl metabolites of methotrexateBiochemical and Biophysical Research Communications, 1973
- Methotrexate toxicity: Correlation with duration of administration, plasma levels, dose and excretion patternPublished by Elsevier ,1972
- NEW APPROACHES TO CHEMOTHERAPY WITH FOLATE ANTAGONISTS: USE OF LEUCOVORIN “RESCUE” AND ENZYMIC FOLATE DEPLETION*Annals of the New York Academy of Sciences, 1971
- The Variability of Individual Tolerance to Methotrexate in Cancer PatientsBritish Journal of Cancer, 1971